Concepedia

Charlotte Beau‐Larvor

CB

Statistics

Publications

6

Citations

185

H-Index

6

Active since

2012

Affiliations

Center of Immunology Pierre Fabre(Current)

Pierre Fabre (France)

Inserm

Charlotte Beau‐Larvor is an author at Center of Immunology Pierre Fabre specializing in pharmacy, targeted cancer therapy, and oncology.

ORCID

Publications per year

2012–2019

6

Publications

6

A novel role for junctional adhesion molecule‐A in tumor proliferation: Modulation by an anti‐JAM‐A monoclonal antibody

Liliane Goetsch, Jean‐François Haeuw, Charlotte Beau‐Larvor et al. · International Journal of Cancer · 2012 · 59 citations · Full text

, , +17

A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells

Matthieu Broussas, Nicolas Boute, Barbara Akla et al. · Molecular Cancer Therapeutics · 2016 · 35 citations · Full text

, , +15

Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors

Barbara Akla, Matthieu Broussas, Noureddine Loukili et al. · Molecular Cancer Therapeutics · 2019 · 30 citations · Full text

, , +17

Absolute and Multiplex Quantification of Antibodies in Serum Using Psaq™ Standards and LC-MS/MS

Dorothée Lebert, Guillaume Picard, Charlotte Beau‐Larvor et al. · Bioanalysis · 2015 · 23 citations

, , +17

A novel antagonist anti‐cMet antibody with antitumor activities targeting both ligand‐dependent and ligand‐independent c‐Met receptors

Alexandra Gonzalez, Matthieu Broussas, Charlotte Beau‐Larvor et al. · International Journal of Cancer · 2016 · 23 citations · Full text

, , +17

1–5 of 6